Literature DB >> 9484768

Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation.

K A Newell1, J M Millis, P M Arnow, D S Bruce, E S Woodle, D C Cronin, G E Loss, H Grewal, T Lissoos, T Schiano, J Mead, J R Thistlethwaite.   

Abstract

Vancomycin-resistant Enterococcus (VRE) has become a significant nosocomial pathogen. For this study, the records of 325 patients who underwent orthotopic liver transplantation (OLT) were reviewed. Thirty-four patients were infected by VRE (incidence of 10.5%, 14% in adults vs. 5% in children, P < 0.01). Common features of patients who developed infections with VRE included previous antibiotic use (25 patients, 15 of whom received vancomycin), co-infection by other pathogens (28 patients), and relaparotomy following OLT (20 patients). Pulmonary and/or renal failure preceded infection by VRE in 11 and 4 adult patients, respectively. Biliary complications were exceedingly common in patients infected by VRE (28 patients) and significantly increased the risk of infection by VRE (21.5% vs. 3.1% for patients without biliary complications, P < 0.0001). Mortality associated with VRE infections was high (56% vs. 19% for patients not infected by VRE, P < 0.0005). The most frequent cause of death was sepsis (16 of 19 patient deaths), often polymicrobial. The high incidence of infection by VRE following OLT, the lack of effective antibiotics for the treatment of VRE, and the association of VRE with patient mortality emphasizes the need to define the risk factors associated with VRE infection. We suggest early surgical intervention to treat complications that may predispose patients to infection by VRE.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9484768     DOI: 10.1097/00007890-199802150-00027

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

1.  Molecular epidemiology of vancomycin-resistant Enterococcus faecium in a large urban hospital over a 5-year period.

Authors:  W E Bischoff; T M Reynolds; G O Hall; R P Wenzel; M B Edmond
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 2.  Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci.

Authors:  Stephan Harbarth; Sara Cosgrove; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

3.  Sepsis in the severely immunocompromised patient.

Authors:  Andre C Kalil; Steven M Opal
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

4.  Vancomycin-resistant Enterococcus faecium: catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilm.

Authors:  Issam I Raad; Hend A Hanna; Maha Boktour; Gassan Chaiban; Ray Y Hachem; Tanya Dvorak; Russell Lewis; Barbara E Murray
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 5.  Treatment options for vancomycin-resistant enterococcal infections.

Authors:  Peter K Linden
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients.

Authors:  Debra D Poutsiaka; Serena Skiffington; Kenneth B Miller; Susan Hadley; David R Snydman
Journal:  J Infect       Date:  2006-12-26       Impact factor: 6.072

Review 7.  Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge.

Authors:  Guilherme Santoro-Lopes; Erika Ferraz de Gouvêa
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

8.  VRE in cirrhotic patients.

Authors:  Melissa Barger; Emily Blodget; Sol Pena; Wendy Mack; Tse-Ling Fong
Journal:  BMC Infect Dis       Date:  2019-08-13       Impact factor: 3.667

9.  Reference group choice and antibiotic resistance outcomes.

Authors:  Keith S Kaye; John J Engemann; Essy Mozaffari; Yehuda Carmeli
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

10.  Epidemiological Analysis of Extended-Spectrum Beta-Lactamase-Producing Bacterial Infections in Adult Live Donor Liver Transplant Patients.

Authors:  Ajeet Singh; Deepak Govil; Usha Krishan Baveja; Anand Gupta; Neha Tandon; Shrikanth Srinivasan; Sachin Gupta; Sweta J Patel; Sanjiv Saigal; Arvinder Singh Soin
Journal:  Indian J Crit Care Med       Date:  2018-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.